SONX Stock Overview
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Sonendo, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.13 |
| 52 Week High | US$2.95 |
| 52 Week Low | US$0.091 |
| Beta | 2.04 |
| 1 Month Change | -50.75% |
| 3 Month Change | -86.19% |
| 1 Year Change | -94.91% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.54% |
Recent News & Updates
Recent updates
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%
Nov 10
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price
Apr 19Sonendo unit PIPStek files patent infringement lawsuit against Biolase
Jan 04GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M
Nov 09Sonendo announces $63 million private placement
Sep 23Sonendo: Painful Debut For This Dental Play
Nov 07Shareholder Returns
| SONX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 32.5% | 1.0% | 1.1% |
| 1Y | -94.9% | -2.3% | 11.7% |
Return vs Industry: SONX underperformed the US Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: SONX underperformed the US Market which returned 11.7% over the past year.
Price Volatility
| SONX volatility | |
|---|---|
| SONX Average Weekly Movement | 29.3% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SONX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week.
Volatility Over Time: SONX's weekly volatility has increased from 20% to 29% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 253 | Bjarne Bergheim | https://sonendo.com |
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
Sonendo, Inc. Fundamentals Summary
| SONX fundamental statistics | |
|---|---|
| Market Cap | US$7.27m |
| Earnings (TTM) | -US$60.89m |
| Revenue (TTM) | US$44.40m |
0.2x
P/S Ratio-0.1x
P/E RatioIs SONX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SONX income statement (TTM) | |
|---|---|
| Revenue | US$44.40m |
| Cost of Revenue | US$32.84m |
| Gross Profit | US$11.56m |
| Other Expenses | US$72.45m |
| Earnings | -US$60.89m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.12 |
| Gross Margin | 26.04% |
| Net Profit Margin | -137.14% |
| Debt/Equity Ratio | 98.5% |
How did SONX perform over the long term?
See historical performance and comparison